Optimal Biologic Dose
Showing 1 - 25 of >10,000
Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Obesity Trial in Durham (Etanercept Optimal dosing)
Not yet recruiting
- Juvenile Idiopathic Arthritis
- +2 more
- Etanercept Optimal dosing
-
Durham, North CarolinaDuke University Medical Center
Oct 10, 2022
Pancreatitis, Cholangiopancreatography, Endoscopic Retrograde, Indomethacin Trial in Suzhou (Indomethacin Suppository)
Recruiting
- Pancreatitis
- +2 more
- Indomethacin Suppository
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Sep 2, 2023
Labor Pain Trial (Bupivacaine Hydrochloride)
Not yet recruiting
- Labor Pain
- Bupivacaine Hydrochloride
- (no location specified)
Nov 18, 2023
Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)
Active, not recruiting
- Myeloproliferative Neoplasm
- +4 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023
Knee Osteoarthritis Trial (FURESTEM-OA Kit Inj., Placebo)
Not yet recruiting
- Knee Osteoarthritis
- FURESTEM-OA Kit Inj.
- Placebo
- (no location specified)
Jul 12, 2023
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 2, 2022
Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)
Not yet recruiting
- Obstructive Sleep Apnea
- IHL-42X Low Dose
- +5 more
- (no location specified)
Nov 22, 2023
Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)
Not yet recruiting
- Renal Cell Carcinoma
- +4 more
- Olaparib
- +4 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 13, 2023
Optimal Gastrointestinal Absorption of Omega-3 Trial in Brisbane (Product 1 - AquaCelle Fish Oil Triglyceride, Product 2 -
Not yet recruiting
- Optimal Gastrointestinal Absorption of Omega-3
- Product 1 - AquaCelle Fish Oil Triglyceride
- +2 more
-
Brisbane, Queensland, AustraliaRDC Global Pty Ltd
Aug 8, 2022
Onchocerciasis Trial in Hohoe (Moxidectin)
Completed
- Onchocerciasis
-
Hohoe, Volta Region, GhanaUniversity of Health and Allied Services School of Public Health
Dec 13, 2022
Labor Pain, Analgesia Trial in Boston (Bupivacaine Hydrochloride)
Completed
- Labor Pain
- Analgesia
- Bupivacaine Hydrochloride
-
Boston, MassachusettsBrigham and Women's Hospital
Aug 2, 2022
Insomnia Chronic Trial in Aarhus (eCBT-I)
Active, not recruiting
- Insomnia Chronic
- eCBT-I
-
Aarhus, Midtjylland, DenmarkAarhus University
Dec 12, 2022
Inflammatory Bowel Disease, Crohn Disease, Ulcerative Colitis Trial in Boston (vitamin D3)
Recruiting
- Inflammatory Bowel Disease
- +3 more
- vitamin D3
-
Boston, MassachusettsBoston Children's Hospital
Jul 28, 2022
Aging, Exercise Trial in Cali (Exercise Dose-Response)
Recruiting
- Aging
- Exercise
- Exercise Dose-Response
-
Cali, Valle Del Cauca, ColombiaRetos Salud Mental
Sep 23, 2023
Mild Alzheimer Trial in Seoul (PM012, PM012 Placebo, Donepezil)
Recruiting
- Mild Alzheimer Disease
- PM012
- +3 more
-
Seoul, Seongdon-gu, Korea, Republic ofMediforum
Apr 13, 2023
Post Operative Pain Trial in Seattle (Dose of 0.5% Ropivacaine)
Recruiting
- Post Operative Pain
- Dose of 0.5% Ropivacaine
-
Seattle, WashingtonVirginia Mason Medical Center
May 11, 2023
Advanced Malignant Solid Tumor Trial in Hangzhou (Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection)
Not yet recruiting
- Advanced Malignant Solid Tumor
- Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,Zhejiang University School of Medi
Jul 25, 2022
Knee Disease, Quality of Recovery Trial in Nantong (ultrasound-guided high fascia iliaca compartment block)
Recruiting
- Knee Disease
- Quality of Recovery
- ultrasound-guided high fascia iliaca compartment block
-
Nantong, Jiangsu, ChinaAffiliated Hospital of Nantong University
Sep 5, 2022
Crohn Disease, Ulcerative Colitis Trial (Adalimumab-680LT, Control)
Not yet recruiting
- Crohn Disease
- Ulcerative Colitis
- Adalimumab-680LT
- Control
- (no location specified)
Oct 30, 2023
Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)
Recruiting
- Axial Spondyloarthritis
- Tapered doses of TNFi
- Standard dose of TNFi
-
Toronto, Ontario, CanadaUniversity Health Network - Toronto Western Hospital
Nov 21, 2022
Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl Trial in Cairo (Pilocaine 2%)
Completed
- Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl
- Pilocaine 2%
-
Cairo, EgyptAhmed Abdalla Mohamed
Feb 4, 2023
Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)
Active, not recruiting
- Glioblastoma Multiforme
- VBI-1901
- +2 more
-
Los Angeles, California
- +3 more
Jun 27, 2022
Coagulation; Intravascular Trial in Miami (Protamine fixed dose, Protamine ratio dose)
Recruiting
- Coagulation; Intravascular
- Protamine fixed dose
- Protamine ratio dose
-
Miami, Florida
- +1 more
Jul 28, 2022
Surgery Trial in Charleston (Dose Response Curve Placebo, Dose Response Curve N-acetylcysteine 50 mg/kg, Dose Response Curve
Active, not recruiting
- Surgery
- Dose Response Curve Placebo
- +5 more
-
Charleston, South CarolinaMedical University of South Carolina
Jul 22, 2022
Influenza Trial in Baltimore, Durham (Influenza RG-A/Texas/71/2017 (H3N2) Challenge, Placebo)
Recruiting
- Influenza
- Influenza RG-A/Texas/71/2017 (H3N2) Challenge
- Placebo
-
Baltimore, Maryland
- +1 more
Aug 4, 2022